Shield Diagnostics (UK) granted European patent for heart attack test:
This article was originally published in Clinica
Executive Summary
Sheild Diagnostics (UK) has been granted a European patent for its test for activated factor XII (AFT). The test, developed in collaboration with the University of Oxford, has potential application in the management of patients at risk of heart attack.